{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:46:31Z","timestamp":1790786791501,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T00:00:00Z","timestamp":1617926400000},"content-version":"vor","delay-in-days":98,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG063845"],"award-info":[{"award-number":["R01AG063845"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA177272"],"award-info":[{"award-number":["R01CA177272"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21NS099654"],"award-info":[{"award-number":["R21NS099654"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014071","name":"National Science Foundation LFO","doi-asserted-by":"publisher","award":["DGE-1762114"],"award-info":[{"award-number":["DGE-1762114"]}],"id":[{"id":"10.13039\/100014071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004008","name":"National Institute of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004008","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jbc.2021.100657","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T11:47:03Z","timestamp":1618573623000},"page":"100657","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Optimized serum stability and specificity of an \u03b1v\u03b26 integrin-binding peptide for tumor targeting"],"prefix":"10.1016","volume":"296","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9000-2293","authenticated-orcid":false,"given":"Ian I.","family":"Cardle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7477-3063","authenticated-orcid":false,"given":"Michael C.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1443-4996","authenticated-orcid":false,"given":"Suzie H.","family":"Pun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1799-5908","authenticated-orcid":false,"given":"Drew L.","family":"Sellers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2021.100657_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"C.\u00a0A. Cancer J. Clin."},{"key":"10.1016\/j.jbc.2021.100657_bib2","doi-asserted-by":"crossref","first-page":"a005074","DOI":"10.1101\/cshperspect.a005074","article-title":"Integrins in cell migration","volume":"3","author":"Huttenlocher","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jbc.2021.100657_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","article-title":"Every step of the way: Integrins in cancer progression and metastasis","volume":"18","author":"Hamidi","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2021.100657_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10555-006-7888-7","article-title":"Reciprocal interactions between adhesion receptor signaling and MMP regulation","volume":"25","author":"Munshi","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.jbc.2021.100657_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00441-016-2474-y","article-title":"The role of integrins in TGF\u03b2 activation in the tumour stroma","volume":"365","author":"Khan","year":"2016","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.jbc.2021.100657_bib6","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1097\/MJT.0000000000000053","article-title":"Arginine-glycine-aspartate\u2013binding integrins as therapeutic and diagnostic targets","volume":"23","author":"Sun","year":"2016","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.jbc.2021.100657_bib7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/cancers9090110","article-title":"Integrins as therapeutic targets: Successes and cancers","volume":"9","author":"Raab-Westphal","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2021.100657_bib8","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1242\/jcs.108.6.2241","article-title":"Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling","volume":"108","author":"Breuss","year":"1995","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.jbc.2021.100657_bib9","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/path.5320","article-title":"The integrin \u03b1v\u03b26 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy","volume":"249","author":"Reader","year":"2019","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.jbc.2021.100657_bib10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jhep.2009.12.006","article-title":"The \u03b1v\u03b26 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma","volume":"52","author":"Patsenker","year":"2010","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.jbc.2021.100657_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/hep.28274","article-title":"Integrin \u03b1v\u03b26 critically regulates hepatic progenitor cell function and promotes ductular reaction, fibrosis, and tumorigenesis","volume":"63","author":"Peng","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jbc.2021.100657_bib12","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1158\/0008-5472.CAN-07-0245","article-title":"A\u00a0peptide selected by biopanning identifies the integrin \u03b1v\u03b26 as a prognostic biomarker for nonsmall cell lung cancer","volume":"67","author":"Elayadi","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2021.100657_bib13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.tranon.2018.02.013","article-title":"Integrin \u03b1v\u03b26 promotes lung cancer proliferation and metastasis through upregulation of IL-8-mediated MAPK\/ERK signaling","volume":"11","author":"Yan","year":"2018","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.jbc.2021.100657_bib14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1158\/0008-5472.CAN-07-2307","article-title":"Antibody-Mediated blockade of integrin \u03b1v\u03b26 by a transforming growth factor-\u03b2\u2013regulated mechanism","volume":"68","author":"Koopman Van Aarsen","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2021.100657_bib15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/path.2168","article-title":"Overexpression of the \u03b1v\u03b26 integrin in cervical squamous cell carcinoma is a prognostic factor for decreased survival","volume":"212","author":"Hazelbag","year":"2007","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.jbc.2021.100657_bib16","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju169","article-title":"Therapeutic targeting of integrin \u03b1v\u03b26 in breast cancer","volume":"106","author":"Moore","year":"2014","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.jbc.2021.100657_bib17","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hed.21166","article-title":"Cyclic \u03b1v\u03b26-targeting peptide selected from biopanning with clinical potential for head and neck squamous cell carcinoma","volume":"32","author":"Hsiao","year":"2010","journal-title":"Head Neck"},{"key":"10.1016\/j.jbc.2021.100657_bib18","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.3748\/wjg.v21.i24.7457","article-title":"Integrin \u03b1v\u03b26 sustains and promotes tumor invasive growth in colon cancer progression","volume":"21","author":"Yang","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jbc.2021.100657_bib19","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1177\/002215540205001010","article-title":"\u03b1v\u03b26 integrin-A marker for the malignant potential of epithelial ovarian cancer","volume":"50","author":"Ahmed","year":"2002","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.jbc.2021.100657_bib20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s12032-013-0580-1","article-title":"Clinical significance of integrin \u03b1v\u03b26 expression effects on gastric carcinoma invasiveness and progression via cancer-associated fibroblasts","volume":"30","author":"Zhuang","year":"2013","journal-title":"Med. Oncol."},{"key":"10.1016\/j.jbc.2021.100657_bib21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1368-8375(01)00062-8","article-title":"Tenascin and \u03b26 integrin are overexpressed in floor of mouth in situ carcinomas and invasive squamous cell carcinomas","volume":"38","author":"Regezi","year":"2002","journal-title":"Oral Oncol."},{"key":"10.1016\/j.jbc.2021.100657_bib22","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1172\/JCI200523183","article-title":"Transcriptional activation of integrin \u03b26 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma","volume":"115","author":"Bates","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jbc.2021.100657_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40291-020-00450-1","article-title":"Integrin \u03b1\u03bd\u03b26 protein expression and prognosis in solid tumors: A meta-analysis","volume":"24","author":"Desnoyers","year":"2020","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.jbc.2021.100657_bib24","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1016\/S0021-9258(18)42622-1","article-title":"Characterization of the integrin alpha v beta 6 as a fibronectin-binding protein","volume":"267","author":"Busk","year":"1992","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100657_bib25","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1046\/j.1523-1747.2001.01352.x","article-title":"\u03b1v\u03b26 integrin upregulates matrix metalloproteinase 9 and promotes migration of normal oral keratinocytes","volume":"116","author":"Thomas","year":"2001","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.jbc.2021.100657_bib26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/sj.bjc.6600545","article-title":"Binding of TGF-\u03b21 latency-associated peptide (LAP) to \u03b1\u03bd\u03b26 integrin modulates behaviour of squamous carcinoma cells","volume":"87","author":"Thomas","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbc.2021.100657_bib27","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1083\/jcb.200312172","article-title":"Integrin \u03b1\u03bd\u03b26-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1","volume":"165","author":"Annes","year":"2004","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.jbc.2021.100657_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature10152","article-title":"Latent TGF-\u03b2 structure and activation","volume":"474","author":"Shi","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2021.100657_bib29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/1097-0215(20010601)92:5<641::AID-IJC1243>3.0.CO;2-P","article-title":"\u03b1v\u03b26 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9","volume":"92","author":"Thomas","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jbc.2021.100657_bib30","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/sj.bjc.6600480","article-title":"Integrin \u03b1v\u03b26-associated ERK2 mediates MMP-9 secretion in colon cancer cells","volume":"87","author":"Gu","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbc.2021.100657_bib31","doi-asserted-by":"crossref","first-page":"26533","DOI":"10.1074\/jbc.M401736200","article-title":"The integrin cytoplasmic-tail motif EKQKVDLSTDC is sufficient to promote tumor cell invasion mediated by matrix metalloproteinase (MMP)-2 or MMP-9","volume":"279","author":"Morgan","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2021.100657_bib32","first-page":"333","article-title":"Molecular imaging of integrin \u03b1v\u03b26 expression in living subjects","volume":"4","author":"Liu","year":"2014","journal-title":"Am. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jbc.2021.100657_bib33","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2174\/138945009788680374","article-title":"Defining the role of integrin \u03b1v\u03b26 in cancer","volume":"10","author":"Bandyopadhyay","year":"2009","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jbc.2021.100657_bib34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1359-6446(04)03104-6","article-title":"Phage display-derived peptides as therapeutic alternatives to antibodies","volume":"9","author":"Ladner","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jbc.2021.100657_bib35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drudis.2009.10.009","article-title":"Synthetic therapeutic peptides: Science and market","volume":"15","author":"Vlieghe","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jbc.2021.100657_bib36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1756-8722-5-70","article-title":"Targeted drug delivery for cancer therapy: The other side of antibodies","volume":"5","author":"Firer","year":"2012","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.jbc.2021.100657_bib37","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s40425-019-0705-y","article-title":"Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy","volume":"7","author":"Liu","year":"2019","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.jbc.2021.100657_bib38","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/362566a0","article-title":"Structure of a major immunogenic site on foot-and-mouth disease virus","volume":"362","author":"Logan","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2021.100657_bib39","doi-asserted-by":"crossref","first-page":"9657","DOI":"10.1074\/jbc.M610461200","article-title":"Structure-Function analysis of Arg-Gly-Asp helix motifs in \u03b1v\u03b26 integrin ligands","volume":"282","author":"DiCara","year":"2007","journal-title":"J.\u00a0Biol. Chem. .."},{"key":"10.1016\/j.jbc.2021.100657_bib40","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1158\/0008-5472.CAN-07-1026","article-title":"Use of a peptide derived from foot-and-mouth disease virus for the noninvasive imaging of human cancer: Generation and evaluation of 4-[18F]fluorobenzoyl A20FMDV2 for in\u00a0vivo imaging of integrin \u03b1v\u03b26 expression with positron emission tomography","volume":"67","author":"Hausner","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2021.100657_bib41","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000443180","article-title":"Pharmacological characterization of the \u03b1v\u03b26 integrin binding and internalization kinetics of the foot-and-mouth disease virus derived peptide A20FMDV2","volume":"97","author":"Slack","year":"2016","journal-title":"Pharmacology"},{"key":"10.1016\/j.jbc.2021.100657_bib42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2967\/jnmt.117.203547","article-title":"A\u00a0microdose PET study of the safety, immunogenicity, biodistribution, and radiation dosimetry of 18F-FB-A20FMDV2 for imaging the integrin \u03b1v\u03b26","volume":"46","author":"Keat","year":"2018","journal-title":"J.\u00a0Nucl. Med. Technol."},{"key":"10.1016\/j.jbc.2021.100657_bib43","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1158\/1078-0432.CCR-18-2665","article-title":"Preclinical development and first-in-human imaging of the integrin \u03b1v\u03b26 with [18F]\u03b1v\u03b26-Binding peptide in metastatic carcinoma","volume":"25","author":"Hausner","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2021.100657_bib44","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.7150\/thno.38702","article-title":"Integrin \u03b1v\u03b26-specific therapy for pancreatic cancer developed from foot-and-mouth-disease virus","volume":"10","author":"Moore","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jbc.2021.100657_bib45","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ymthe.2016.10.012","article-title":"Targeting of aberrant \u03b1v\u03b26 integrin expression in solid tumors using chimeric antigen receptor-engineered T cells","volume":"25","author":"Whilding","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jbc.2021.100657_bib46","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00259-019-04586-z","article-title":"Clinical quantification of the integrin \u03b1v\u03b26 by [18F]FB-A20FMDV2 positron emission tomography in healthy and fibrotic human lung (PETAL Study)","volume":"47","author":"Lukey","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.jbc.2021.100657_bib47","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijrobp.2020.02.014","article-title":"Integrin \u03b1v\u03b26 positron emission tomography imaging in lung cancer patients treated with pulmonary radiation therapy","volume":"107","author":"Saleem","year":"2020","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.jbc.2021.100657_bib48","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2967\/jnumed.120.255364","article-title":"\u03b1v\u03b26-Targeted molecular PET\/CT imaging of the lungs after SARS-CoV-2 infection","volume":"61","author":"Foster","year":"2020","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.jbc.2021.100657_bib49","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1158\/1078-0432.CCR-11-1116","article-title":"Pharmacokinetically stabilized cystine Knot peptides that bind alpha-v-beta-6 integrin with single-digit nanomolar affinities for detection of pancreatic cancer","volume":"18","author":"Kimura","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2021.100657_bib50","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1158\/0008-5472.CAN-08-4410","article-title":"Targeted in\u00a0vivo imaging of integrin \u03b1v\u03b26 with an improved radiotracer and its relevance in a pancreatic tumor model","volume":"69","author":"Hausner","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2021.100657_bib51","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2967\/jnumed.114.150680","article-title":"The effect of Bi-terminal PEGylation of an integrin \u03b1v\u03b2\u2086-targeted 18F peptide on pharmacokinetics and tumor uptake","volume":"56","author":"Hausner","year":"2015","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.jbc.2021.100657_bib52","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.1128\/JVI.00577-06","article-title":"Specificity of the VP1 GH loop of foot-and-mouth disease virus for \u03b1v integrins","volume":"80","author":"Burman","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2021.100657_bib53","doi-asserted-by":"crossref","first-page":"5946","DOI":"10.1021\/ja400119t","article-title":"A\u00a0perfluoroaryl-cysteine SNAr chemistry approach to unprotected peptide stapling","volume":"135","author":"Spokoyny","year":"2013","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2021.100657_bib54","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1021\/acs.bioconjchem.6b00502","article-title":"Engineering an affinity-enhanced peptide through optimization of cyclization chemistry","volume":"27","author":"Ngambenjawong","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jbc.2021.100657_bib55","doi-asserted-by":"crossref","first-page":"10961","DOI":"10.1021\/acsnano.9b01515","article-title":"Targeting ligands deliver model drug cargo into the central nervous system along autonomic neurons","volume":"13","author":"Sellers","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jbc.2021.100657_bib56","doi-asserted-by":"crossref","first-page":"228236","DOI":"10.1128\/JVI.74.1.228-236.2000","article-title":"Integrins \u03b12\u03b21 and \u03b14\u03b21 can mediate SA11 rotavirus attachment and entry into cells","volume":"74","author":"Hewish","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2021.100657_bib57","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1128\/JVI.01480-07","article-title":"Foot-and-Mouth disease virus forms a highly stable, EDTA-resistant complex with its principal receptor, integrin \u03b1v\u03b26: Implications for Infectiousness","volume":"82","author":"DiCara","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2021.100657_bib58","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejmech.2017.05.008","article-title":"Structure-activity relationship study of the tumour-targeting peptide A20FMDV2 via modification of Lys16, Leu13, and N- and\/or C-terminal functionality","volume":"136","author":"Hung","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.jbc.2021.100657_bib59","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1073\/pnas.0407677102","article-title":"Partial D-amino acid substitution: Improved enzymatic stability and preserved Ab recognition of a MUC2 epitope peptide","volume":"102","author":"Tugyi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2021.100657_bib60","series-title":"Protein Identification and Analysis Tools on the ExPASy Server BT - the Proteomics Protocols Handbook","first-page":"571","author":"Gasteiger","year":"2005"},{"key":"10.1016\/j.jbc.2021.100657_bib61","series-title":"Peptide Optimization and Conjugation Strategies in the Development of Molecularly Targeted Magnetic Resonance Imaging Contrast Agents BT - Therapeutic Peptides: Methods and Protocols","first-page":"185","author":"Kolodziej","year":"2014"},{"key":"10.1016\/j.jbc.2021.100657_bib62","doi-asserted-by":"crossref","first-page":"7719","DOI":"10.1021\/acs.jmedchem.5b00612","article-title":"Phenylalanine and phenylglycine analogues as arginine mimetics in dengue protease inhibitors","volume":"58","author":"Weigel","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2021.100657_bib63","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1158\/1535-7163.MCT-15-0544","article-title":"Optimization of RGD-containing cyclic peptides against \u03b1v\u03b23 integrin","volume":"15","author":"Wang","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2021.100657_bib64","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/cancers9090116","article-title":"Exploring the role of RGD-recognizing integrins in cancer","volume":"9","author":"Nieberler","year":"2017","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jbc.2021.100657_bib65","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jmb.2008.07.013","article-title":"Engineering a single-chain Fv antibody to \u03b1v\u03b26 integrin using the specificity-determining loop of a foot-and-mouth disease virus","volume":"382","author":"Kogelberg","year":"2008","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2021.100657_bib66","doi-asserted-by":"crossref","first-page":"11019","DOI":"10.1039\/c2ra21655h","article-title":"NMR relaxation and structural elucidation of peptides in the presence and absence of trifluoroethanol illuminates the critical molecular nature of integrin \u03b1v\u03b26 ligand specificity","volume":"2","author":"Wagstaff","year":"2012","journal-title":"RSC Adv."},{"key":"10.1016\/j.jbc.2021.100657_bib67","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jconrel.2021.01.015","article-title":"Replacement of L-amino acid peptides with D-amino acid peptides mitigates anti-PEG antibody generation against polymer-peptide conjugates in mice","volume":"331","author":"Sylvestre","year":"2021","journal-title":"J.\u00a0Control Release"},{"key":"10.1016\/j.jbc.2021.100657_bib68","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkw329","article-title":"PEP-FOLD3: Faster de novo structure prediction for linear peptides in solution and in complex","volume":"44","author":"Lamiable","year":"2016","journal-title":"Nucleic Acids Res."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925821004452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925821004452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:06:15Z","timestamp":1758240375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925821004452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":68,"alternative-id":["S0021925821004452"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2021.100657","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimized serum stability and specificity of an \u03b1v\u03b26 integrin-binding peptide for tumor targeting","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2021.100657","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"100657"}}